Neurovascular Devices/Interventional Neurology Market: Global Regulatory Landscape
                     Neurovascular Devices/Interventional 
Neurology Market: Global Regulatory 
Landscape
Neurovascular devices/interventional neurology is a specialized branch of
medical technology that focuses on the diagnosis as well as treatment of
conditions  affecting  the  blood  vessels  of  the  brain  and  spinal  cord.  It
constitutes  minimally  invasive  procedures  performed  by  skilled
neurosurgeons or interventional radiologists in order to address a range of
neurological disorders. As per Inkwood Research, the global neurovascular
devices/interventional  neurology  market is  set  to  grow  with
a CAGR of 5.23% during the forecast period, 2023-2032. 
Regulation  plays  a  vital  role  in  the  field  of  neurovascular
devices/interventional neurology, ensuring the safety and effectiveness of
medical interventions and procedures. Governing bodies in this domain
work  to  safeguard  patients  from  potential  health  risks,  establishing  a
secure working environment and upholding public health and well-being. 
Further,  regulations  are  essential  for  standardizing  and  supervising
neurological devices, ensuring that healthcare bodies provide safe care to
all patients and medical professionals.
This blog analyzes the global neurovascular devices/interventional neurology
market  in  terms  of  the  regulatory  frameworks  across  major  geographical
regions.
Role of Regulatory Bodies in Neurovascular 
Devices/Interventional Neurology 
 North America –
The United States Food and Drug Administration (FDA) Center for
Devices  and  Radiological  Health  (CDRH) is  responsible  for
guaranteeing that patients in the United States have prompt access to
top-notch, secure, and efficient medical devices. Operating within CDRH,
the Division  of  Neurological  and  Physical  Medicine
Devices assesses medical innovations that interact with the central and
peripheral  nervous  system  (neurotechnologies),  encompassing
neurointerventional medical devices employed in stroke treatment. 
  Food  and  Drug  Administration  (FDA)  Premarket 
Notification  [510(k)] –  A  significant  portion  of
neurovascular  devices  fall  under  the  Class  II
classification,  making  them  eligible  for  the  510(k)
pathway. This regulatory route permits manufacturers to
demonstrate  the  “substantial  equivalence”  of  their
product to an existing PMA-exempt device already in the
market.  Successful  demonstration  of  this  equivalence
allows  for  marketing  approval;  in  contrast  to  the  PMA
process,  the  510(k)  pathway  offers  a  faster  and  more
cost-effective approach.
  Quality  Management  System  (QMS)  – In  Canada,
manufacturers  are  required  to  establish  a  Quality
Management System to ensure the consistent production
and regulation  of  their  products  according to accepted
standards.  Moreover,  Health  Canada  often  requires
compliance with the ISO 13485 standard for maintaining
the optimal quality of medical devices.
 
Market  Position: As  per  Inkwood  Research,  the North  America
neurovascular devices/interventional neurology market is set to progress
with a CAGR of 5.39% between 2023 to 2032.
 
 Europe –
In the European Union (EU), medical devices must undergo a conformity
assessment in order to demonstrate they adhere to legal requirements.
This measure ensures that devices and equipment are safe and perform
as intended. While regulated at the EU Member State level, the European
Medicines Agency (EMA) is closely engaged in the regulatory process. 
Let’s take a closer look from a country-level perspective:
  Unique  Device  Identification  –  In  Spain,  medical
devices, particularly neurovascular devices, are required
to carry a Unique Device Identification (UDI) code under
the IVDR as well  as MDR.  Moreover,  these devices are
identified  and  tracked  using  the  UDI  throughout  their
lifecycle.
 Medical Device Regulation – A medical device cannot
be  put  on  the  market  in  Great  Britain  unless  it  has
a UKCA or a CE marking. A CE marking demonstrates that
the  medical  device,  encompassing  neurovascular
devices,  also  complies  with  the  relevant  EU  medical
device  regulations  and  that  the  manufacturer  has
checked  that  the  product  meets ‘EU  safety,  health  or
environmental  requirements.’ These  regulations
delineate the requirements for performance and safety
standards that medical devices must meet prior to their
market availability.
  UK Medicines and Healthcare Products Regulatory 
Agency (MHRA) –  In June 2022,  the  United  Kingdom
MHRA announced new plans to enhance patient safety by
strengthening the regulation of  medical  devices.  These
include  providing  assurance to  the public  and patients
regarding  the  performance  as  well  as  safety  of  the
highest-risk medical devices, including those that require
implantation. 
  Conformity  Assessment  – Manufacturers  of
neurovascular  devices  in  France  must  undergo  a
conformity  assessment  process  to  demonstrate
compliance  with  relevant  regulations.  This  assessment
evaluates  aspects  such  as  design,  manufacturing
processes,  clinical  data,  and  others  to  ensure  the
device’s performance and safety.
 
Market  Position:  Inkwood  Research  estimates  that  the Europe
neurovascular  devices/interventional  neurology market is  anticipated to
capture a revenue share of 26.16% by 2032.
 
 Asia-Pacific –
Despite  Asia  having 60% of  the world’s  population  and providing  large
market  potential,  Asian  healthcare  expenditure  constitutes  only  15%    o f
the global healthcare expenditure.  The rapidly aging population and the
increasing  prevalence  of  chronic  diseases  are  among  the  key  drivers
contributing to the rise in total healthcare spending on medical devices,
including  neurovascular  devices,  in  the  region.  Accordingly,  several
countries in the Asia-Pacific have implemented policies and programs to
reduce regulatory burdens, while improving the quality as well as cost-
effectiveness of present regulations. 
Some of these are – 
  National Medical Products Administration (NMPA)  –
In China, the NMPA reviews the registration application
and  accompanying  documentation,  conducting
inspections  as  necessary.  Once  the  product  fulfills  all
regulatory  and  safety  criteria,  it  receives  approval  for
marketing and sales in China.
  Pharmaceutical  Affairs  and  Medical  Devices  Act 
(PMDA) –  The  PMD  Act  serves  as  Japan’s  primary
medical  device legislation.  Manufacturers  are obligated
to comply with the Act’s standards, encompassing quality
management, safety, and post-market surveillance.
  Central  Drugs  Standard  Control  Organisation 
(CDSCO) – The CDSCO, under the Directorate General of
Health  Services,  Ministry  of  Health  &  Family  Welfare,
Government of India, is the National Regulatory Authority
(NRA)  of  India.  CDSCO and state  regulators  are jointly
responsible  for  granting  licenses  for  specialized
categories of critical drugs. 
 
Market  Position: The Asia-Pacific  neurovascular  devices/interventional
neurology  market  is  projected  to  be  the  fastest-growing  region,
progressing with a CAGR of 5.46% from 2023 to 2032.  
As  demonstrated,  a  robust  regulatory  framework  is  essential  to
standardize  and  oversee  neurovascular  interventions,  ensuring  that
practitioners and facilities adhere to established guidelines. They also help
provide  secure  and  reliable  care  to  patients  undergoing  neurovascular
procedures,  thus  paving the  way for  the  notable  growth  of  the  global
neurovascular devices/interventional neurology market over the upcoming
years.
FAQs:
1. What is interventional neurology?
A: Interventional neurology is a medical specialty 
focused on treating neurological conditions using 
minimally invasive techniques. These procedures 
involve accessing the blood vessels of the brain or spine
to treat conditions such as aneurysms, stroke, and 
vascular malformations.
2. Can neurovascular devices help treat strokes?
A: Yes; certain devices like stent retrievers are used to 
remove blood clots causing ischemic strokes, restoring 
blood flow to the brain.